Diseases of the genitourinary system. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: Use of Dehydroepiandrosterone tablet, 25 mg three times a day till 6 weeks. Intervention 2: Control group: No treatment.
Treatment - Drugs
Intervention group: Use of Dehydroepiandrosterone tablet, 25 mg three times a day till 6 weeks.
Sponsors
Vice chancellor of Mazandaran University of Medical Science.
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Infertile women aged 20 to 45 years; normal hysterosalpingography; AMH levels < 1.5 ng/ml; antral follicular counts (AFC) < 7 in both ovaries; prior less than three failed in vitro fertilization cycles. Exclusion criteria: Normal ovarian response in ovulatory cycles or in vitro fertilization cycles.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-mullerian hormone rate. Timepoint: Before intervention, six weeks after intervention. Method of measurement: Laboratory kits.;Clinical pregnancy rates. Timepoint: Forth weeks after embryo transfer. Method of measurement: Questionnare. | — |
Secondary
| Measure | Time frame |
|---|---|
| Miscarriage rates. Timepoint: Till twenty weeks after embryo transfer. Method of measurement: File.;Antral Follicular counts. Timepoint: Before treatment, six weeks after treatments. Method of measurement: ultrasonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Zamaniyan
Infertility Center, Department of Obstetrics and Gynecology, Mazandaran University of Medical Scienc
Outcome results
None listed